» Articles » PMID: 2006915

Biosynthesis of Bone Proteins [SPP-1 (secreted Phosphoprotein-1, Osteopontin), BSP (bone Sialoprotein) and SPARC (osteonectin)] in Association with Mineralized-tissue Formation by Fetal-rat Calvarial Cells in Culture

Overview
Journal Biochem J
Specialty Biochemistry
Date 1991 Mar 1
PMID 2006915
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

To determine the relationship between the expression of bone proteins and the formation of mineralized-tissue matrix, the biosynthesis of non-collagenous bone proteins was studied in cultures of fetal-rat calvarial cells, which form mineralized nodules of bone-like tissue in the presence of beta-glycerophosphate. The temporal pattern of protein synthesis in both mineralizing and non-mineralizing cultures was studied by metabolic labelling with [35S]methionine, 35SO4(2-) or 32PO4(3-) over a 5-day period. After a 24 h labelling period, the culture media were harvested and the cell layers extracted sequentially with aq. 0.5 M-NH3, followed by 4 M-guanidinium chloride (GdmCl), 0.5 M-EDTA and a second extraction with 4 M-GdmCl. Protein associated with collagenous bone matrix was analysed after digestion with bacterial collagenase. On the basis of [35S]methionine labelling, the major proteins extracted from the mineralizing matrix were secreted phosphoprotein-1 (SPP-1; osteopontin), bone sialoprotein (BSP) and a 14 kDa phosphoprotein. The presence of SPP-1 and BSP in the conditioned media of both mineralizing and non-mineralizing cultures and their incorporation into the mineralizing nodules indicated that these proteins associate with preformed mineral crystals. However, some BSP was also present in GdmCl extracts and, together with a 35 kDa sulphated protein, was released from a bacterial-collagenase digestion of the tissue residue in both non-mineralizing and mineralizing cultures. Two forms of sulphated SPP-1 were identified, a highly phosphorylated 44 kDa species being the predominant form in the mineralized matrix. The BSP was more highly sulphated but less phosphorylated than SPP-1. Bone SPARC (secreted protein, acid and rich in cysteine) protein (osteonectin) was present almost entirely in the conditioned media and did not incorporate 32PO4(3-) or 35SO4(2-). The SPP-1 and the 14 kDa protein were susceptible to thrombin digestion, the 44 kDa SPP-1 being specifically cleaved into 28 and 26 kDa fragments. The fragments were labelled uniformly with [35S]methionine, but the 28 kDa fragment incorporated more 35SO4(2-), but less 32PO4(3-), than the 26 kDa fragment. These studies demonstrate that SPP-1 and BSP are the major osteoblast-derived bone proteins to bind to the bone mineral. That BSP also binds to the collagenous bone matrix indicates a potential role for this protein in linking the hydroxyapatite with collagen.

Citing Articles

Combination of a Synthetic Bioceramic Associated with a Polydioxanone-Based Membrane as an Alternative to Autogenous Bone Grafting.

Frigerio P, de Moura J, Pitol-Palin L, Monteiro N, Mourao C, Shibli J Biomimetics (Basel). 2024; 9(5).

PMID: 38786494 PMC: 11117809. DOI: 10.3390/biomimetics9050284.


enhances osteogenic differentiation in adipose-derived mesenchymal stem cells.

Mohamad-Fauzi N, Shaw C, Foutouhi S, Hess M, Kong N, Kol A Front Cell Dev Biol. 2023; 11:1077350.

PMID: 37009487 PMC: 10055666. DOI: 10.3389/fcell.2023.1077350.


Vitamin D Effects on Osteoblastic Differentiation of Mesenchymal Stem Cells from Dental Tissues.

Posa F, Di Benedetto A, Colaianni G, Cavalcanti-Adam E, Brunetti G, Porro C Stem Cells Int. 2016; 2016:9150819.

PMID: 27956902 PMC: 5124467. DOI: 10.1155/2016/9150819.


Enzyme replacement therapy for treating mucopolysaccharidosis type IVA (Morquio A syndrome): effect and limitations.

Tomatsu S, Sawamoto K, Shimada T, Bober M, Kubaski F, Yasuda E Expert Opin Orphan Drugs. 2016; 3(11):1279-1290.

PMID: 26973801 PMC: 4788508. DOI: 10.1517/21678707.2015.1086640.


Impact of enzyme replacement therapy and hematopoietic stem cell transplantation in patients with Morquio A syndrome.

Tomatsu S, Sawamoto K, Almeciga-Diaz C, Shimada T, Bober M, Chinen Y Drug Des Devel Ther. 2015; 9:1937-53.

PMID: 25897204 PMC: 4389814. DOI: 10.2147/DDDT.S68562.


References
1.
Mark M, Prince C, Oosawa T, Gay S, Bronckers A, Butler W . Immunohistochemical demonstration of a 44-KD phosphoprotein in developing rat bones. J Histochem Cytochem. 1987; 35(7):707-15. DOI: 10.1177/35.7.3295029. View

2.
Senger D, Perruzzi C, Papadopoulos A, Tenen D . Purification of a human milk protein closely similar to tumor-secreted phosphoproteins and osteopontin. Biochim Biophys Acta. 1989; 996(1-2):43-8. DOI: 10.1016/0167-4838(89)90092-7. View

3.
Tenenbaum H, Heersche J . Differentiation of osteoblasts and formation of mineralized bone in vitro. Calcif Tissue Int. 1982; 34(1):76-9. DOI: 10.1007/BF02411212. View

4.
Fisher L, MCBRIDE O, Termine J, Young M . Human bone sialoprotein. Deduced protein sequence and chromosomal localization. J Biol Chem. 1990; 265(4):2347-51. View

5.
Romberg R, Werness P, Lollar P, Riggs B, Mann K . Isolation and characterization of native adult osteonectin. J Biol Chem. 1985; 260(5):2728-36. View